DUBLIN–(BUSINESS WIRE)–The “Gastric Ulcers – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Gastric Ulcers epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered The United States EU5 … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Thyroid Eye Disease Treatments Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Thyroid Eye Disease Treatments Market is projected to reach USD 428.35 million by 2027 from USD 249.41 million in 2021, at a CAGR 9.43% during the forecast period. Market Statistics: The report … [Read more…]
High-profile investors led by T. Rowe Price and Fidelity back a new standard of care for cardiovascular disease NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $192 million. This new funding brings the total raised by the fast-growing … [Read more…]
Rachel brings diverse Marketing Communications experience to Versant Health BALTIMORE–(BUSINESS WIRE)–#avp—Versant Health, a leading national managed vision care company and wholly-owned subsidiary of MetLife, is proud to welcome Rachel Pokay as Assistant Vice President of Brand Activation and Market Enablement, effective July 25, 2022. Rachel has over 15 years of marketing and communications experience, building … [Read more…]
Reducing preparation steps to help support patient safety LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes. Fresenius Kabi Simplist Glycopyrrolate Injection, USP is the most recent manufacturer-prepared product available in the company’s proprietary, ready-to-administer portfolio of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Viral Vector & Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period. … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Contract Manufacturing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Contract Manufacturing Market is projected to reach USD 157,658.35 million by 2027 from USD 97,178.18 million in 2021, at a CAGR 8.39% during the forecast period. Market Statistics: The report provides market … [Read more…]
– The handbook presents information for each life stage of Type 1 galactosemia, with the aim of guiding patients and caregivers from newborn diagnosis through adulthood to help understand the disease lexicon, build a care team and educate their support network on the disease – Created by the Galactosemia Foundation and made possible through support … [Read more…]
Adam Feldman, Pedro Santos and Will Sloss all joined VHP as Pre-MBA Associates in 2018 LOS ANGELES & STAMFORD, Conn.–(BUSINESS WIRE)–Varsity Healthcare Partners (“VHP”), a leading lower middle market healthcare services private equity investment firm, today announced the promotion of Adam Feldman, Pedro Santos and Will Sloss to Vice President from Senior Associate. In this … [Read more…]
The Apthera extended depth of focus IOL uses proprietary small aperture technology to filter out peripheral defocused light, allowing only focused light to reach the retina. Results from the U.S. pivotal trial showed Apthera IOL subjects achieved statistically superior uncorrected intermediate and near vision, and equivalent distance vision and contrast sensitivity compared to control subjects. … [Read more…]
